AI assistant
Venus Concept Inc. — Director's Dealing 2022
Nov 22, 2022
35449_dirs_2022-11-22_e1e8e452-f285-4da3-84b5-f3a6a397b1a7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Venus Concept Inc. (VERO)
CIK: 0001409269
Period of Report: 2022-11-18
Reporting Person: Kong Garheng (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-11-18 | Voting Convertible Preferred Stock | $0 | P | 335000 | Acquired | Common Stock (3350000) | Indirect |
Footnotes
F1: The Voting Preferred Stock will convert into shares of Common Stock on a one for ten basis (i) at the option the holder or (ii) at the option of the Company within 30 days following the occurrence of certain events. The Voting Preferred Stock votes with the Common Stock on an as-converted basis. The Voting Preferred Stock does not expire.
F2: The shares were purchased by HealthQuest Partners II, L.P. ("HealthQuest"). HealthQuest Venture Management II, L.L.C. ("HQVM II"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. The Reporting Person and HQVM II disclaim beneficial ownership of all shares held by HealthQuest except to the extent of any pecuniary interest therein.